FAP and neoplasm: The newly synthesized heterodimeric PET radiotracer [68Ga]Ga-FAPI-RGD, with dual FAP and integrin αvβ3 targeting ability, showed significantly improved tumor uptake, prolonged tumor retention, tumor-targeting efficiency and pharmacokinetics compared with [68Ga]Ga-labeled FAPI and RGD monospecific tracers.